Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment
Clinical trial NCT01530334 · COMPLETED
Trial details
- NCT number
- NCT01530334
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-07-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.